Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 8
2012 17
2013 14
2014 17
2015 15
2016 16
2017 20
2018 22
2019 15
2020 17
2021 15
2022 11
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study.
Yu EY, Piulats JM, Gravis G, Fong PCC, Todenhöfer T, Laguerre B, Arranz JA, Oudard S, Massard C, Heinzelbecker J, Nordquist LT, Carles J, Kolinsky MP, Augustin M, Gurney H, Tafreshi A, Li XT, Qiu P, Poehlein CH, Schloss C, de Bono JS. Yu EY, et al. Among authors: todenhofer t. Eur Urol. 2023 Jan;83(1):15-26. doi: 10.1016/j.eururo.2022.08.005. Epub 2022 Aug 30. Eur Urol. 2023. PMID: 36055895 Free article. Clinical Trial.
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
Seiler R, Ashab HAD, Erho N, van Rhijn BWG, Winters B, Douglas J, Van Kessel KE, Fransen van de Putte EE, Sommerlad M, Wang NQ, Choeurng V, Gibb EA, Palmer-Aronsten B, Lam LL, Buerki C, Davicioni E, Sjödahl G, Kardos J, Hoadley KA, Lerner SP, McConkey DJ, Choi W, Kim WY, Kiss B, Thalmann GN, Todenhöfer T, Crabb SJ, North S, Zwarthoff EC, Boormans JL, Wright J, Dall'Era M, van der Heijden MS, Black PC. Seiler R, et al. Among authors: todenhofer t. Eur Urol. 2017 Oct;72(4):544-554. doi: 10.1016/j.eururo.2017.03.030. Epub 2017 Apr 5. Eur Urol. 2017. PMID: 28390739
Molecular markers in bladder cancer.
Soria F, Krabbe LM, Todenhöfer T, Dobruch J, Mitra AP, Inman BA, Gust KM, Lotan Y, Shariat SF. Soria F, et al. Among authors: todenhofer t. World J Urol. 2019 Jan;37(1):31-40. doi: 10.1007/s00345-018-2503-4. Epub 2018 Sep 26. World J Urol. 2019. PMID: 30259123 Free PMC article. Review.
Editorial Comment.
Todenhöfer T. Todenhöfer T. J Urol. 2020 Jan;203(1):81. doi: 10.1097/01.JU.0000602792.03998.76. Epub 2019 Oct 3. J Urol. 2020. PMID: 31580195 No abstract available.
Can urinary biomarkers replace cystoscopy?
Maas M, Bedke J, Stenzl A, Todenhöfer T. Maas M, et al. Among authors: todenhofer t. World J Urol. 2019 Sep;37(9):1741-1749. doi: 10.1007/s00345-018-2505-2. Epub 2018 Oct 3. World J Urol. 2019. PMID: 30283995 Review.
Editorial Comment.
Todenhöfer T. Todenhöfer T. J Urol. 2020 Jul;204(1):77. doi: 10.1097/JU.0000000000000803.01. Epub 2020 Apr 28. J Urol. 2020. PMID: 32343216 No abstract available.
Trimodal therapy for muscle-invasive bladder cancer.
Mathes J, Rausch S, Todenhöfer T, Stenzl A. Mathes J, et al. Among authors: todenhofer t. Expert Rev Anticancer Ther. 2018 Dec;18(12):1219-1229. doi: 10.1080/14737140.2018.1535314. Epub 2018 Oct 17. Expert Rev Anticancer Ther. 2018. PMID: 30324833 Review.
[Systemic treatment of advanced prostate cancer].
Kretschmer A, Todenhöfer T. Kretschmer A, et al. Among authors: todenhofer t. Urologe A. 2020 Dec;59(12):1565-1576. doi: 10.1007/s00120-020-01381-9. Urologe A. 2020. PMID: 33201295 Review. German.
161 results